Dylan A Kotliar, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lassa Fever | 5 | 2024 | 97 | 1.450 |
Why?
|
Lassa virus | 6 | 2024 | 99 | 1.010 |
Why?
|
Ebolavirus | 3 | 2023 | 250 | 0.900 |
Why?
|
Single-Cell Analysis | 5 | 2024 | 2535 | 0.860 |
Why?
|
Hemorrhagic Fever, Ebola | 3 | 2023 | 424 | 0.750 |
Why?
|
Host-Pathogen Interactions | 2 | 2020 | 1466 | 0.410 |
Why?
|
Visual Cortex | 1 | 2019 | 1081 | 0.380 |
Why?
|
Gene Expression Profiling | 4 | 2020 | 9528 | 0.320 |
Why?
|
Antigens, Viral | 4 | 2020 | 995 | 0.300 |
Why?
|
Epitopes, T-Lymphocyte | 3 | 2020 | 827 | 0.290 |
Why?
|
Software | 1 | 2021 | 4464 | 0.280 |
Why?
|
Isovaleryl-CoA Dehydrogenase | 1 | 2024 | 5 | 0.230 |
Why?
|
Hemorrhagic Fevers, Viral | 1 | 2023 | 23 | 0.220 |
Why?
|
Nucleoproteins | 2 | 2020 | 110 | 0.210 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2024 | 172 | 0.200 |
Why?
|
Seroepidemiologic Studies | 1 | 2024 | 404 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2020 | 4652 | 0.190 |
Why?
|
Interferons | 2 | 2024 | 716 | 0.180 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2017 | 1642 | 0.180 |
Why?
|
Bystander Effect | 1 | 2020 | 89 | 0.170 |
Why?
|
Lasers, Solid-State | 1 | 2022 | 183 | 0.170 |
Why?
|
Myelopoiesis | 1 | 2020 | 135 | 0.170 |
Why?
|
Antibodies, Viral | 3 | 2020 | 3213 | 0.150 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2020 | 434 | 0.150 |
Why?
|
Macaca mulatta | 2 | 2023 | 2341 | 0.140 |
Why?
|
Viral Envelope Proteins | 1 | 2020 | 640 | 0.130 |
Why?
|
Sequence Analysis, RNA | 2 | 2021 | 2039 | 0.130 |
Why?
|
Genes, Reporter | 2 | 2020 | 1525 | 0.130 |
Why?
|
Fever | 1 | 2024 | 1607 | 0.130 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2020 | 1442 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3667 | 0.130 |
Why?
|
Africa, Western | 3 | 2021 | 160 | 0.130 |
Why?
|
Laser Therapy | 1 | 2022 | 1108 | 0.130 |
Why?
|
Disaster Planning | 1 | 2021 | 558 | 0.120 |
Why?
|
Genome-Wide Association Study | 4 | 2024 | 12808 | 0.120 |
Why?
|
Genome, Viral | 1 | 2018 | 674 | 0.120 |
Why?
|
Cluster Analysis | 1 | 2021 | 2721 | 0.120 |
Why?
|
Sierra Leone | 3 | 2020 | 171 | 0.120 |
Why?
|
Genetic Techniques | 1 | 2016 | 427 | 0.110 |
Why?
|
Organoids | 1 | 2019 | 740 | 0.100 |
Why?
|
Disease | 1 | 2018 | 675 | 0.100 |
Why?
|
Quantitative Trait Loci | 2 | 2018 | 2133 | 0.100 |
Why?
|
Nigeria | 3 | 2021 | 781 | 0.100 |
Why?
|
HLA Antigens | 1 | 2018 | 1339 | 0.100 |
Why?
|
Epidemics | 1 | 2018 | 516 | 0.100 |
Why?
|
Brain | 1 | 2019 | 27158 | 0.100 |
Why?
|
Gene Expression Regulation | 3 | 2020 | 11924 | 0.100 |
Why?
|
Alternative Splicing | 1 | 2016 | 1103 | 0.090 |
Why?
|
Genetic Diseases, Inborn | 1 | 2016 | 606 | 0.090 |
Why?
|
Carcinoma | 1 | 2022 | 2325 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2599 | 0.090 |
Why?
|
Bayes Theorem | 3 | 2018 | 2353 | 0.090 |
Why?
|
RNA, Viral | 1 | 2018 | 2867 | 0.090 |
Why?
|
Multifactorial Inheritance | 1 | 2018 | 1425 | 0.080 |
Why?
|
Antigens, CD | 1 | 2020 | 4033 | 0.080 |
Why?
|
Models, Genetic | 1 | 2019 | 3446 | 0.080 |
Why?
|
rab GTP-Binding Proteins | 1 | 2010 | 247 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4780 | 0.080 |
Why?
|
GTPase-Activating Proteins | 1 | 2010 | 467 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2016 | 2448 | 0.070 |
Why?
|
Genetic Variation | 3 | 2018 | 6613 | 0.070 |
Why?
|
Algorithms | 2 | 2019 | 14073 | 0.070 |
Why?
|
Computer Simulation | 1 | 2019 | 6258 | 0.060 |
Why?
|
Macrophages | 1 | 2020 | 5784 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2020 | 12795 | 0.060 |
Why?
|
Cytokines | 1 | 2020 | 7438 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2020 | 10451 | 0.060 |
Why?
|
Animals | 6 | 2023 | 168939 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5860 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2020 | 11657 | 0.050 |
Why?
|
Mutation | 2 | 2017 | 30214 | 0.050 |
Why?
|
Oxidoreductases | 1 | 2024 | 409 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4787 | 0.050 |
Why?
|
Humans | 18 | 2024 | 766812 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3828 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20146 | 0.050 |
Why?
|
DNA Methylation | 1 | 2014 | 4427 | 0.040 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2021 | 168 | 0.040 |
Why?
|
Immune Sera | 1 | 2020 | 605 | 0.040 |
Why?
|
HLA-DQ Antigens | 1 | 2020 | 190 | 0.040 |
Why?
|
Phylogeography | 1 | 2018 | 72 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 40149 | 0.040 |
Why?
|
Transcription Factors | 1 | 2018 | 12159 | 0.040 |
Why?
|
Survivors | 2 | 2020 | 2379 | 0.040 |
Why?
|
Disease Reservoirs | 1 | 2018 | 123 | 0.040 |
Why?
|
Keratinocytes | 1 | 2022 | 876 | 0.040 |
Why?
|
Cross Reactions | 1 | 2020 | 826 | 0.040 |
Why?
|
Validation Studies as Topic | 1 | 2018 | 162 | 0.040 |
Why?
|
Receptors, Virus | 1 | 2021 | 652 | 0.040 |
Why?
|
Zoonoses | 1 | 2018 | 180 | 0.040 |
Why?
|
Rodentia | 1 | 2018 | 262 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2018 | 434 | 0.030 |
Why?
|
Blood Cells | 1 | 2018 | 309 | 0.030 |
Why?
|
Species Specificity | 1 | 2020 | 2413 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2016 | 378 | 0.030 |
Why?
|
Markov Chains | 1 | 2018 | 974 | 0.030 |
Why?
|
Sulfites | 1 | 2014 | 83 | 0.030 |
Why?
|
Spondylitis, Ankylosing | 1 | 2016 | 158 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2020 | 2062 | 0.030 |
Why?
|
Immunoassay | 1 | 2018 | 744 | 0.030 |
Why?
|
Haplotypes | 1 | 2020 | 2726 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2018 | 1996 | 0.030 |
Why?
|
Gene Library | 1 | 2016 | 1065 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2020 | 1377 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2024 | 4349 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2018 | 1527 | 0.030 |
Why?
|
Colitis, Ulcerative | 1 | 2024 | 1920 | 0.030 |
Why?
|
Mice | 1 | 2019 | 81898 | 0.020 |
Why?
|
Melanoma | 1 | 2010 | 5702 | 0.020 |
Why?
|
Crohn Disease | 1 | 2024 | 2286 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2016 | 751 | 0.020 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2014 | 657 | 0.020 |
Why?
|
Viral Proteins | 1 | 2018 | 1801 | 0.020 |
Why?
|
Gene Expression | 1 | 2024 | 7585 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2021 | 4249 | 0.020 |
Why?
|
Phylogeny | 1 | 2018 | 2840 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1836 | 0.020 |
Why?
|
CpG Islands | 1 | 2014 | 1208 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2024 | 2429 | 0.020 |
Why?
|
Binding Sites | 1 | 2018 | 6013 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2626 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2024 | 3788 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2016 | 17089 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2017 | 1893 | 0.020 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2010 | 257 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2020 | 13411 | 0.020 |
Why?
|
Female | 7 | 2024 | 396532 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6507 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14762 | 0.020 |
Why?
|
Signal Transduction | 2 | 2024 | 23618 | 0.020 |
Why?
|
Male | 6 | 2024 | 364154 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2014 | 21162 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 88902 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9326 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2829 | 0.020 |
Why?
|
Vaccination | 1 | 2018 | 3435 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 2045 | 0.020 |
Why?
|
Adult | 4 | 2024 | 223305 | 0.020 |
Why?
|
Alleles | 1 | 2016 | 6896 | 0.010 |
Why?
|
Protein Transport | 1 | 2010 | 1944 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2017 | 7612 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 59939 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17609 | 0.010 |
Why?
|
Genome, Human | 1 | 2014 | 4443 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8734 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14653 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8623 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16722 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22248 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 16044 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 18076 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 65286 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 81657 | 0.010 |
Why?
|
Middle Aged | 2 | 2018 | 223267 | 0.010 |
Why?
|
Child | 1 | 2020 | 80670 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74889 | 0.010 |
Why?
|